Paricalcitol 0.004 MG Oral Capsule — RxCUI 577324
RxNorm drug concept · Semantic clinical drug
RxCUI 577324
Semantic clinical drug · SCD
● Current RxNorm concept 18 FDA products
33 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI577324
Official nameParicalcitol 0.004 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asparicalcitol 4 MCG Oral Capsule
FDA products mapped18
Package NDCs mapped33
Reported Medicaid activity (SDUD)918 prescriptions · 7 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Paricalcitol: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Paricalcitol isn't repairing your kidneys directly — what it's doing is fixing a problem caused by kidney disease. When your kidneys are damaged, they can't activate vitamin D the...
- What exactly is paricalcitol doing for my kidneys?
- High calcium — called hypercalcemia — can sneak up on you, but there are signs to watch for: feeling unusually tired or weak, trouble thinking clearly, loss of appetite, nausea, vo...
- How will I know if my calcium gets too high while I'm on this medication?
🕸️ Concept Web — How Paricalcitol 0.004 MG Oral Capsule Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Paricalcitol 0.004 MG Oral Capsule
RxCUI 577324 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Paricalcitol
73710IN
-
Paricalcitol
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Paricalcitol Oral Capsule
577314SCDF -
Paricalcitol Oral Product
1161357SCDG -
Paricalcitol Pill
1161358SCDG -
Oral Capsule
316965DF -
Oral Product
1151131DFG -
Pill
1151133DFG
-
Paricalcitol Oral Capsule
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Paricalcitol 0.004 MG
577323SCDC
-
Paricalcitol 0.004 MG
Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Paricalcitol 0.004 MG
SCDC · 577323 -
Paricalcitol Oral Capsule
SCDF · 577314 -
Paricalcitol Oral Product
SCDG · 1161357 -
Paricalcitol Pill
SCDG · 1161358
📦 FDA Products & Package NDCs
18 products · 33 package NDCs
33 package NDCs map to RxCUI 577324 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 25000-0012-03 | 30 CAPSULE, LIQUID FILLED in 1 BOTTLE (25000-012-03) | Paricalcitol | MARKSANS PHARMA LIMITED | 2016-12-31 |
| 25000-0012-50 | 4 BAG in 1 BOX (25000-012-50) / 10000 CAPSULE, LIQUID FILLE... | Paricalcitol | MARKSANS PHARMA LIMITED | 2016-12-31 |
| 25000-0014-03 | 30 CAPSULE, LIQUID FILLED in 1 BOTTLE (25000-014-03) | Paricalcitol | MARKSANS PHARMA LIMITED | 2016-12-31 |
| 25000-0014-49 | 4 BAG in 1 BOX (25000-014-49) / 7000 CAPSULE, LIQUID FILLED... | Paricalcitol | MARKSANS PHARMA LIMITED | 2016-12-31 |
| 25000-0017-03 | 30 CAPSULE, LIQUID FILLED in 1 BOTTLE (25000-017-03) | Paricalcitol | MARKSANS PHARMA LIMITED | 2016-12-31 |
| 25000-0017-49 | 4 BAG in 1 BOX (25000-017-49) / 7000 CAPSULE, LIQUID FILLED... | Paricalcitol | MARKSANS PHARMA LIMITED | 2016-12-31 |
| 49483-0687-03 | 30 CAPSULE, LIQUID FILLED in 1 BOTTLE (49483-687-03) | Paricalcitol | TIME CAP LABORATORIES, INC | 2017-01-03 |
| 49483-0688-03 | 30 CAPSULE, LIQUID FILLED in 1 BOTTLE (49483-688-03) | Paricalcitol | TIME CAP LABORATORIES, INC | 2017-01-03 |
| 49483-0689-03 | 30 CAPSULE, LIQUID FILLED in 1 BOTTLE (49483-689-03) | Paricalcitol | TIME CAP LABORATORIES, INC | 2017-01-03 |
| 55111-0663-01 | 100 CAPSULE, LIQUID FILLED in 1 BOTTLE (55111-663-01) | Paricalcitol | Dr. Reddy's Laboratories Limited | 2014-06-25 |
| 55111-0663-05 | 500 CAPSULE, LIQUID FILLED in 1 BOTTLE (55111-663-05) | Paricalcitol | Dr. Reddy's Laboratories Limited | 2014-06-25 |
| 55111-0663-30 | 30 CAPSULE, LIQUID FILLED in 1 BOTTLE (55111-663-30) | Paricalcitol | Dr. Reddy's Laboratories Limited | 2014-06-25 |
| 55111-0663-81 | 3 BLISTER PACK in 1 CARTON (55111-663-81) / 10 CAPSULE, LIQ... | Paricalcitol | Dr. Reddy's Laboratories Limited | 2014-06-25 |
| 55111-0664-01 | 100 CAPSULE, LIQUID FILLED in 1 BOTTLE (55111-664-01) | Paricalcitol | Dr. Reddy's Laboratories Limited | 2014-06-25 |
| 55111-0664-05 | 500 CAPSULE, LIQUID FILLED in 1 BOTTLE (55111-664-05) | Paricalcitol | Dr. Reddy's Laboratories Limited | 2014-06-25 |
| 55111-0664-30 | 30 CAPSULE, LIQUID FILLED in 1 BOTTLE (55111-664-30) | Paricalcitol | Dr. Reddy's Laboratories Limited | 2014-06-25 |
| 55111-0664-81 | 3 BLISTER PACK in 1 CARTON (55111-664-81) / 10 CAPSULE, LIQ... | Paricalcitol | Dr. Reddy's Laboratories Limited | 2014-06-25 |
| 55111-0665-01 | 100 CAPSULE, LIQUID FILLED in 1 BOTTLE (55111-665-01) | Paricalcitol | Dr. Reddy's Laboratories Limited | 2014-06-25 |
| 55111-0665-05 | 500 CAPSULE, LIQUID FILLED in 1 BOTTLE (55111-665-05) | Paricalcitol | Dr. Reddy's Laboratories Limited | 2014-06-25 |
| 55111-0665-30 | 30 CAPSULE, LIQUID FILLED in 1 BOTTLE (55111-665-30) | Paricalcitol | Dr. Reddy's Laboratories Limited | 2014-06-25 |
| 55111-0665-81 | 3 BLISTER PACK in 1 CARTON (55111-665-81) / 10 CAPSULE, LIQ... | Paricalcitol | Dr. Reddy's Laboratories Limited | 2014-06-25 |
| 65162-0822-03 | 30 CAPSULE in 1 BOTTLE (65162-822-03) | Paricalcitol | Amneal Pharmaceuticals LLC | 2016-01-15 |
| 65162-0822-09 | 90 CAPSULE in 1 BOTTLE (65162-822-09) | Paricalcitol | Amneal Pharmaceuticals LLC | 2016-01-15 |
| 65162-0823-03 | 30 CAPSULE in 1 BOTTLE (65162-823-03) | Paricalcitol | Amneal Pharmaceuticals LLC | 2016-01-15 |
| 65162-0823-09 | 90 CAPSULE in 1 BOTTLE (65162-823-09) | Paricalcitol | Amneal Pharmaceuticals LLC | 2016-01-15 |
| 65162-0824-03 | 30 CAPSULE in 1 BOTTLE (65162-824-03) | Paricalcitol | Amneal Pharmaceuticals LLC | 2016-01-15 |
| 65162-0824-09 | 90 CAPSULE in 1 BOTTLE (65162-824-09) | Paricalcitol | Amneal Pharmaceuticals LLC | 2016-01-15 |
| 65862-0936-30 | 30 CAPSULE, LIQUID FILLED in 1 BOTTLE (65862-936-30) | Paricalcitol | Aurobindo Pharma Limited | 2016-01-14 |
| 65862-0937-30 | 30 CAPSULE, LIQUID FILLED in 1 BOTTLE (65862-937-30) | Paricalcitol | Aurobindo Pharma Limited | 2016-01-14 |
| 65862-0938-30 | 30 CAPSULE, LIQUID FILLED in 1 BOTTLE (65862-938-30) | Paricalcitol | Aurobindo Pharma Limited | 2016-01-14 |
| 69452-0145-13 | 30 CAPSULE in 1 BOTTLE, PLASTIC (69452-145-13) | Paricalcitol | Bionpharma Inc. | 2016-08-16 |
| 69452-0146-13 | 30 CAPSULE in 1 BOTTLE, PLASTIC (69452-146-13) | Paricalcitol | Bionpharma Inc. | 2016-08-16 |
| 69452-0147-13 | 30 CAPSULE in 1 BOTTLE, PLASTIC (69452-147-13) | Paricalcitol | Bionpharma Inc. | 2016-08-16 |
Observed labelers:
Dr. Reddy's Laboratories Limited (12) ·
Amneal Pharmaceuticals LLC (6) ·
MARKSANS PHARMA LIMITED (6) ·
Aurobindo Pharma Limited (3) ·
Bionpharma Inc. (3) ·
TIME CAP LABORATORIES, INC (3)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.